Category stocks

Medline Q2 Earnings Call Highlights

Key Points - Medline reported strong second-quarter growth, with net sales up 12% to $7.7 billion, led by a 16% increase in Supply Chain Solutions and a 15% increase in U.S. acute-care sales. The company raised its full-year organic sales growth outlook to 9%-10%. - Adjust

Livanova Q2 Earnings Call Highlights

Key Points - Record Q2 performance: Revenue rose 9.8% year over year on a constant-currency basis to $391 million, while adjusted EPS increased to $1.26 from $1.05, supported by double-digit growth in Cardiopulmonary and Epilepsy. - 2026 outlook raised: LivaNova increased its...<

Limbach Q2 Earnings Call Highlights

Key Points - Second-quarter profitability weakened despite revenue rising 22% to $173.5 million, as gross margin fell to 21.5%, net income declined 39% to $4.7 million, and adjusted EBITDA dropped 22% to $13.9 million. Project timing, softness in healthcare and institution

Lineage Q2 Earnings Call Highlights

Key Points - Second-quarter results exceeded expectations: Adjusted EBITDA was approximately $320 million and AFFO was $198 million, or $0.76 per share, as improved occupancy and cost controls offset trade-related volume pressure. - Full-year guidance improved for core...

Interparfums Q2 Earnings Call Highlights

Key Points - Interparfums maintained its 2026 outlook for approximately $1.48 billion in sales and diluted EPS of $4.85 after reporting 2% sales growth in both the second quarter and first half. - Growth was led by North America, Asia Pacific and Central and South America, while...</stron